Fundraising Fox
Star Therapeutics
South San Francisco, US · 20 known investors
Find your way into Star Therapeutics
Sign up to see every warm intro you have to Star Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Star Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
Founders & leadership
Board
Investors · 20
How we know: Frazier Life Sciences's portfolio page · star-therapeutics.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: OrbiMed's portfolio page · a partner's Signal profile · star-therapeutics.com · the VCSheet dataset · Not right? Tell us
How we know: RA Capital's portfolio page · star-therapeutics.com · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · star-therapeutics.com · the VCSheet dataset · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Viking Global's portfolio page · Not right? Tell us
How we know: star-therapeutics.com · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$250M disclosed across 2 of 3 rounds · 2023–2025
- $125MSeries DSep 2025 · 4 sources
Sanofi Ventures (lead), Viking Global Investors (lead), Agent Capital, Blue Owl Capital, Catalio Capital Management, Cormorant Asset Management, Frazier Life Sciences, GordonMD Global Investments, Janus Henderson Investors, New Leaf Venture Partners, NYBC Ventures, OrbiMed, Qatar Investment Authority (QIA), RA Capital Management, Redmile Group
Source ↗
▶$125MraisedOct 2025 · 21 investors · OtherRule 506(b)
- Jason HaflerDirector
- Nancy StaglianoDirector
- Michelle CarpenterExecutive Officer
- Carl GordonDirector
- Matthew FustDirector
- Amrit NagpalDirector
- Beth SeidenbergDirector
- Sandip PanickerExecutive Officer
- Scott RobertsonExecutive Officer
- Adam RosenthalExecutive Officer, Director
- Maha KatabiDirector
- Gary PatouExecutive Officer
- Offering amount
- $125M
- Amount sold
- $125M
- First sale
- Sep 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Star Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Star Therapeutics do?
- Star Therapeutics develops treatments aimed at addressing real-world patient needs.
- Who founded Star Therapeutics?
- Star Therapeutics was founded by Adam Rosenthal, Nancy Stagliano.
- Who are Star Therapeutics's investors?
- Star Therapeutics's investors include Frazier Life Sciences, OrbiMed, RA Capital, Sanofi Ventures, Sofinnova Ventures, Viking Global, Agent Capital, Blue Owl Capital and 10 more.
- How much funding has Star Therapeutics raised?
- Star Therapeutics has disclosed $250M raised across 2 of its 3 known rounds.
- Where is Star Therapeutics headquartered?
- Star Therapeutics is headquartered in South San Francisco, US.